Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Acquired Immunodeficiency Syndrome

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Acquired Immunodeficiency Syndrome in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dwyer, J1
Le Guelte, A1
Galan Moya, EM1
Sumbal, M1
Carlotti, A1
Douguet, L1
Gutkind, JS1
Grange, PA1
Dupin, N1
Gavard, J1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Acquired Immunodeficiency Syndrome

ArticleYear
Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.
    Oncogene, 2011, Jan-13, Volume: 30, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Androstadienes; Animals; Antigens, CD; Cadherins; Capillary Perm

2011